PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Scientists unlock crucial mechanism driving colliding epidemics of smoking and TB

The discovery opens up new routes to treat and prevent the infectious disease which kills 1.5 million people a year.

2014-11-14
(Press-News.org) DUBLIN, Ireland, November 14th, 2014 - TB is an infectious disease that kills 1.5 million people each year, and smoking is the biggest driver of the global TB epidemic. Medical scientists at Trinity College Dublin and St James's Hospital in Ireland have unlocked the mechanism underlying the connection between smoking and Tuberculosis (TB). This discovery will considerably strengthen anti-smoking efforts to control TB and uncovers new therapy and vaccine options for TB. Their research has just been published in the top respiratory Journal, the American Journal of Respiratory and Critical Care Medicine. The research was funded by the Health Research Board (HRB) and The Royal City of Dublin Hospital Trust.

Tuberculosis spreads from person to person by inhaling infected droplets made when the TB sufferer coughs. The World Health Organization has designated TB a global emergency. Nine million people fall ill with TB each year, and it is the greatest killer worldwide due to a single bacterial infection. Many countries have recurring outbreaks and multi-drug resistant TB cases.

After infection most people do not become ill with TB, but immunosuppressed patients are susceptible. Smoking increases a person's susceptibility to infection by TB, risk of recurrence, mortality and persistent infectiousness. However, until now the exact reason or mechanism behind this connection between smoking and TB has been unknown.

The research team conducted the study with smokers, ex-smokers and non-smokers attending the bronchoscopy suite at St James's Hospital in Dublin. They found that the white blood cells located in the lungs of smokers and ex-smokers, which are responsible for fighting infections, showed a weakened response to the TB infection. In the smoker's lungs, these cells malfunction, and fail to make the chemical messengers that would normally fight the TB bacteria. In fact, the researchers found that these cells suppress the lungs' immunity after infection, which gives the TB bacteria a chance to take over.

Joseph Keane is Professor of Medicine at Trinity and St James's Hospital, HRB Clinician Scientist, and the senior author of the study. He said: "TB remains a huge global health problem, affecting millions worldwide. It has been known for some time that smokers are more susceptible to getting TB and nearly 80% of the world's one billion smokers live in countries of high TB prevalence. Therefore, while HIV is a key driver of the disease, numerically, smoking is more prevalent than HIV, making smoking the biggest global driver of the TB epidemic."

"This study provides evidence which explains the link between smoking and TB and should considerably strengthen anti-smoking efforts to control TB. However, the widespread emergence of multi-drug resistance TB means we badly need new therapy and vaccine options for TB. We are already applying the findings of this study to develop new treatment options."

INFORMATION:

This research was funded by the Health Research Board and The Royal City of Dublin Hospital Trust. Dr Keane is the recipient of the inaugural HRB clinician-scientist award, whose grant funding has been renewed.

Graham Love, Chief Executive at the Health Research Board commented: "Patients worldwide who are affected by TB could benefit from this Irish research. Professor Keane continues to identify relevant research questions from his clinical work. He determinedly pursues the answers during his protected time for research through his HRB Clinician Scientist Award. This is yielding results which could now lead to new treatment options for TB."

The paper is available from: http://www.atsjournals.org/doi/abs/10.1164/rccm.201407-1385OC#.VGPLrfSTNZ0

Notes to editors The HRB Clinician Scientist award is designed specifically to allow clinicians protected time to do research each week while replacing their clinical-facing time so patient service levels remain unchanged.



ELSE PRESS RELEASES FROM THIS DATE:

Sleep apnea may contribute to kidney disease progression

2014-11-14
Philadelphia, PA (November 14, 2014) -- Sleep apnea may accelerate kidney function decline in diabetic patients with kidney disease, according to a study that will be presented at ASN Kidney Week 2014 November 11¬-16 at the Pennsylvania Convention Center in Philadelphia, PA. Type 2 diabetes often contributes to the development of chronic kidney disease (CKD). Because obstructive sleep apnea is common in patients with type 2 diabetes, investigators wonder whether disordered sleep might play a role in the link between diabetes and kidney dysfunction. To investigate, ...

How to get teens and young adults with chronic conditions to take their medications

2014-11-14
Philadelphia, PA (November 14, 2014) -- Many young patients with chronic conditions don't take their medications correctly, but 2 new studies point to ways to address such medication non-adherence. The studies will be presented at ASN Kidney Week 2014 November 11¬-16 at the Pennsylvania Convention Center in Philadelphia, PA. In one study, researchers led by Frederick Kaskel, MD, PhD (Albert Einstein College of Medicine) and Oleh Akchurin, MD (Weill Cornell College of Medicine) looked to see how young patients are using smart phones to help them take their medications. ...

Smartphones team-up with QR codes for secure 3-D displays

2014-11-14
WASHINGTON, Nov. 14, 2014--Quick Response (QR) codes -- the box-shaped symbols that appear on signs, posters, and even business cards -- are a convenient and efficient way of accessing specific web pages with a smartphone or other mobile device. However, new research published today in The Optical Society's (OSA) new high-impact journal Optica, explains how QR codes can do much more. By adding an array of tiny lenses to an ordinary smartphone, a team of optical engineers from the University of Connecticut has found a way to securely display three-dimensional (3-D) images ...

Study predicts likely Ebola cases entering UK and US through airport screening

2014-11-14
Researchers at the University of Liverpool have found that screening for Ebola at airports could be an effective method for preventing the spread of the disease into the UK and US, but due to the long incubation period of the virus, screening won't detect all cases. Published in the Lancet medical journal, the study used a mathematical model to test the probability of infected travellers from West Africa entering the UK and US. The team, from the University's Institute of Infection and Global Health, examined the current growth rate of the epidemic in West Africa alongside ...

Kidney function monitoring vital for people on lithium

2014-11-14
People with bipolar disorder who are being treated with the drug lithium are at risk of acute kidney damage and need careful monitoring, according to new research from the University of East Anglia (UEA) and Norfolk and Suffolk NHS Foundation Trust. Lithium is a mainstay treatment for bipolar disorder and it is known that the drug can cause a loss of kidney function. The new research establishes the link between short-term exposure to high levels and potential damage to the kidneys. It is still not known what the impact of more than a single exposure to high levels ...

DNA sequencing helps identify genetic defects in glaucoma

2014-11-14
Scientists from the University of Liverpool have sequenced the mitochondrial genome in glaucoma patients to help further understanding into the genetic basis for the disease. Glaucoma is a major cause of irreversible blindness, affecting more than 60 million people worldwide, increasing to an estimated 79.6 million people by 2020. It is thought that the condition has genetic origins and many experiments have shown that new sequencing approaches could help understand how the condition develops. Studies on primary open-angle glaucoma - the most common form of glaucoma ...

New insight into common cause of blindness

2014-11-14
Age-related Macular Degeneration (AMD) is the major cause of blindness in the western world, affecting around 50 million people. It has been shown that sufferers are genetically predisposed to develop the condition. One of the most important risk associated genes is called complement factor H (CFH). This encodes a protein called factor H (FH) that is responsible for protecting our eyes from attack by part of our immune system, called the complement system. FH achieves this by sticking to tissues, and when it is present in sufficient quantities it prevents the complement ...

New mechanism for growth control discovered

New mechanism for growth control discovered
2014-11-14
Animal growth is closely regulated by environmental factors such as nutrition. If the nutrition of a growing animal is limited, growth slows down and the eventual size of the animal remains smaller. Insulin-like signaling plays a key role in coordinating growth in response to dietary status in multicellular animals. Doctoral student Kiran Hasygar and Assistant Professor Ville Hietakangas from the Department of Biosciences and Institute of Biotechnology, University of Helsinki, Finland, have now uncovered a new regulatory mechanism coordinating animal growth in response ...

Conventional therapies are less efficient in cancer patients carrying 'BRCA' mutations

Conventional therapies are less efficient in cancer patients carrying BRCA mutations
2014-11-14
Prostate cancer patients carrying inherited mutations in the BRCA genes respond less well to conventional treatment, including surgery and/or radiotherapy - and they also have a lower survival rate than those who are non-carriers of these genetic mutations. Data from the study, which has been published in the journal European Urology, points to the need for new clinical trials aimed at targeting these mutations in order to tailor treatment for these patients. The study has been led by David Olmos and Elena Castro at the Spanish National Cancer Research Centre (CNIO) ...

Expression of SIP1 protein indicates poor prognosis in pharyngeal cancer

2014-11-14
The expression of SIP1 protein in pharyngeal squamous cell carcinoma tumours often indicates an advanced tumour stage, a high risk of recurrence and a poor prognosis, according to research from the University of Eastern Finland. Based on the results, SIP1 is a potential new prognostic factor for clinical use, helping to single out patients with more aggressive tumour behaviour requiring more intensive therapy and closer follow-up. Ms Anna Jouppila-Mättö, MD, presented the results in her doctoral thesis. Although pharyngeal squamous cell carcinoma (PSCC) is a ...

LAST 30 PRESS RELEASES:

Even post-#MeToo, news reporting on sexual violence remains problematic, McGill researchers say

New research illustrates how live events foster social connection

EVs reduce climate pollution, but by how much? New U-M research has the answer

Breakthrough in 3D-printed scaffolds offers hope for spinal cord injury recovery

AASM introduces new patient-reported outcome tool for sleep apnea

Breakthrough in indole chemistry could accelerate drug development

Gut check: Glycemic control, not body weight, may sway how we choose what to eat

Scientists date the origin of Jupiter by studying the formation of “molten rock raindrops”

Chemists develop molecule for important step toward artificial photosynthesis

Dynamic duo: a powerful pair of tools to learn about cells

Scientists discover new '3D genome organizer' linked to fertility and cancer

Mediterranean diet may offset genetic risk of Alzheimer's

New study reveals the role of subtle changes of Northern Westerlies in the East Asian monsoon variability

Are patients with advanced cancer receiving treatment aligned with their goals?

Genetic testing of IVF embryos helps women over 35 conceive faster

Survey: People not aware knee, groin pain can be signs of hip problems

New guideline offers menu of options to help people quit smoking tobacco

"Turning spin loss into energy", developing a key technology for ultra-low power next-generation information devices

Evidence, not ideology, must guide preventive health care

Kids in disadvantaged zip codes face up to 20 times higher odds of gun injuries

Gun injury odds up to 20x higher for kids in disadvantaged ZIP codes

Younger men have higher risk for mortality and cardiovascular disease for type 2 diabetes than type 1 diabetes; whereas for women type 1 diabetes outcomes are worse at all ages

Freeze-framing the cellular world to capture a fleeting moment of cellular activity

Computer hardware advance solves complex optimization problems

SOX2: a key player in prostate cancer progression and treatment resistance

Unlocking the potential of the non-coding genome for precision medicine

Chitinase-3-like protein 1: a novel biomarker for liver disease diagnosis and management

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: August 22, 2025

Charisma Virtual Social Coaching named a finalist for Global Innovation Award

From the atmosphere to the abyss: Iron's role in Earth's climate history

[Press-News.org] Scientists unlock crucial mechanism driving colliding epidemics of smoking and TB
The discovery opens up new routes to treat and prevent the infectious disease which kills 1.5 million people a year.